Group One Trading’s 2seventy bio TSVT Stock Holding History

Group One Trading’s Portfolio TSVT Stock Details TSVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-12,900	Closed	-$63.7K	–	8683
2025 Q1	$63.7K	Buy	12,900 +12,800	+12,800%	+$40.7K	﹤0.01%	4961
2024 Q4	$294	Sell	100 -18,100	-99%	-$74.2K	﹤0.01%	7042
2024 Q3	$85.9K	Sell	18,200 -29,700	-62%	-$134K	﹤0.01%	4298
2024 Q2	$184K	Buy	47,900 +7,500	+19%	+$33.8K	﹤0.01%	3464
2024 Q1	$216K	Buy	40,400 +21,800	+117%	+$103K	﹤0.01%	3501
2023 Q4	$79.4K	Buy	18,600 +16,000	+615%	+$49.2K	﹤0.01%	4655
2023 Q3	$10.2K	Sell	2,600 -51,300	-95%	-$336K	﹤0.01%	6326
2023 Q2	$545K	Buy	53,900 +51,300	+1,973%	+$543K	﹤0.01%	2925
2023 Q1	$26.5K	Buy	2,600 +2,500	+2,500%	+$28.6K	﹤0.01%	5327
2022 Q4	$937	Sell	100 -70,800	-100%	-$999K	﹤0.01%	6844
2022 Q3	$1.03M	Buy	+70,900	New	+$1.05M	﹤0.01%	2554

Other funds holding TSVT

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Group One Trading's TSVT Position: Q2 2025 in Review

Group One Trading sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 50 shares — an estimated $247 sold.

Group One Trading first reported a position in TSVT in Q4 2021 and held it in 6 quarters. The position peaked at $1.43M in Q4 2021. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.

Group One Trading reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
Group One Trading sold 50 2seventy bio shares in Q2 2025, an estimated $247.
Group One Trading first reported a position in 2seventy bio in Q4 2021 and held it in 6 quarters.
Group One Trading's 2seventy bio position peaked at $1.43M in Q4 2021.
2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.

Based on Group One Trading's 13F filing for Q2 2025, filed 14 Aug 2025.